CitraFlow™ 46.7% SF for Vascular Access Device locking

CitraFlow™ 46.7% SF prefilled syringes are filled with an anticoagulant and antimicrobial 46.7% sodium citrate solution. CitraFlow™ 46.7% SF is a proven alternative to heparin to lock Vascular Access Devices. It avoids the risks associated with systemic heparinization and is safe for use in patients with suspected or confirmed Heparin Induced Thrombocytopenia.

Image	Catalogue No.	Description	Qty/Box
	Catalogue No. 38143	CitraFlow™ 46.7% SF, 3ml 46.7% Sodium Citrate solution in 5ml syringe.	Qty/Box 150
	Catalogue No. 38143-1	CitraFlow™ 46.7% SF, twinpack of two 3ml 46.7% Sodium Citrate solution in 5ml syringe.	Qty/Box 100